PCM
HZNP

Prelude Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-135,854
Closed -$15.7M 1378
2023
Q3
$15.7M Buy
135,854
+27,159
+25% +$3.14M 1.02% 6
2023
Q2
$11.2M Sell
108,695
-43,634
-29% -$4.49M 0.73% 10
2023
Q1
$16.6M Buy
152,329
+79,596
+109% +$8.69M 1% 8
2022
Q4
$8.28M Buy
72,733
+63,245
+667% +$7.2M 0.43% 23
2022
Q3
$587K Sell
9,488
-10,305
-52% -$638K 0.02% 581
2022
Q2
$1.58M Buy
19,793
+13,478
+213% +$1.08M 0.04% 297
2022
Q1
$664K Buy
+6,315
New +$664K 0.02% 571
2021
Q4
Sell
-10,982
Closed -$1.2M 2141
2021
Q3
$1.2M Buy
10,982
+3,198
+41% +$350K 0.03% 337
2021
Q2
$729K Buy
7,784
+5,324
+216% +$499K 0.02% 600
2021
Q1
$226K Sell
2,460
-3,260
-57% -$299K 0.01% 894
2020
Q4
$418K Buy
+5,720
New +$418K 0.01% 414
2020
Q3
Hold
0
2096
2020
Q2
Sell
-10,768
Closed -$319K 1874
2020
Q1
$319K Buy
+10,768
New +$319K 0.02% 207
2019
Q4
Sell
-184
Closed -$5K 1952
2019
Q3
$5K Buy
+184
New +$5K ﹤0.01% 1077
2019
Q2
Sell
-275
Closed -$7K 1931
2019
Q1
$7K Buy
+275
New +$7K ﹤0.01% 1223
2017
Q4
Sell
-1,700
Closed -$22K 1753
2017
Q3
$22K Buy
+1,700
New +$22K ﹤0.01% 1185
2017
Q2
Sell
-40,000
Closed -$591K 1895
2017
Q1
$591K Sell
40,000
-300
-0.7% -$4.43K 0.06% 283
2016
Q4
$652K Buy
40,300
+22,000
+120% +$356K 0.08% 254
2016
Q3
$332K Buy
+18,300
New +$332K 0.03% 361
2016
Q1
Sell
-10,800
Closed -$234K 1587
2015
Q4
$234K Buy
+10,800
New +$234K 0.04% 443
2015
Q3
Sell
-2,800
Closed -$97K 1847
2015
Q2
$97K Buy
+2,800
New +$97K 0.01% 836
2014
Q3
Sell
-2,000
Closed -$32K 2112
2014
Q2
$32K Buy
+2,000
New +$32K ﹤0.01% 1470